Schizophrenia substance-abuse disorders

The mood disorders were once called affective disorders and are grouped into two main categories unipolar and bipolar. The unipolar depressive disorders include major depressive disorder and dysthymic disorder the bipolar disorders include bipolar 1, bipolar II, bipolar not otherwise specified, and cyclothymic disorder. Other mood disorders are substance-induced mood disorders and mood disorders due to a general medical condition. In addition, mood disturbance commonly occurs as a symptom in other psychiatric disorders including dementia, post-traumatic stress disorder, substance abuse disorders, and schizophrenia. 

HCPC has 250 beds and an average of about 5,000 admissions per year. The mean age of patients treated at HCPC is 36 years. The most common psychiatric disorders treated at HCPC are schizophrenia, other psychotic conditions, bipolar disorders, ma-j or depression, and other mood disorders. Many of these disorders are caused by substance abuse or are present in patients with substance abuse disorders or conditions. 

The DRD2 and ANKK1 genes are located approximately 10,000 nucleotides apart on chromosome llq22-23. Variants in both genes have been found to be associated with several psychiatric diseases such as schizophrenia, as well as with substance abuse disorders, including alcohol, heroin, nicotine, cocaine, opioid, gambling, methamphetamine, and polysubstance addiction [30-37]. 

It is important to screen patients for co-occurring mental disorders, and their presence may become more apparent during the stabilization or maintenance phases of schizophrenia treatment. Examples include substance abuse disorders, depression, obsessive-compulsive disorder, and panic disorder. As co-occurring disorders will limit symptom and functional improvement and increase the risk of relapse, it is critical that they be appropriately treated. Pharmacological and nonpharmacological interventions specific for the co-occurring disorder should be implemented in combination with evidence-based treatment for schizophrenia. 

Many types of mental disorders have been cited. Broad categories include anxiety disorders, mood disorders, personality disorders, schizophrenia, substance abuse and dependence and several others. See Snyder (1988), at 17. 

Psychosocial morbidity association. Cannabis dependence is a prevalent comorbid substance use disorder among patients early in the course of a schizophrenia-spectrum disorder. Among 29 eligible patients, 18 participated in the study. First-episode patients with comorbid cannabis dependence (n = 8) reported significantly greater childhood physical and sexual abuse compared with those without comorbid cannabis dependence (n = 10). The result indicated the preliminary evidence of an association between childhood maltreatment and cannabis dependence among this especially vulnerable population. Child-... 

Although genetic influences on the dynamics of drug response have been studied in a wide range of disorders, most of the studies have been carried out in only the past few years. Disorders and behaviors studied include Alzheimer s disease, schizophrenia, depression, suicide, anxiety, obsessive-compulsive disorder (OCD), substance abuse, smoking, and alcoholism. Across these disorders, however, there has been a focus on only a handful of neuroeffector systems. These include apolipoprotein and the cholinergic system (in Alzhei-... 

In a 1994 study Teplin evaluated 728 male jail detainees, and found that nearly two-thirds of this population had a psychiatric disorder with antisocial personality disorder (ASP), the most common diagnosis at 50%. However, 35% of the population had a current diagnosis other than ASP, and two-thirds had previously been given a lifetime diagnosis other than ASP. Substance abuse was common, with a 62% lifetime prevalence. More than one out of three detainees had a severe mental disorder (schizophrenia, bipolar affective disorder, or major depression). In another study, 693 homicide offenders were evaluated and elevated rates of schizophrenia and ASP were found (Eronen et al., 1996). Earlier studies found schizophrenia in 29%-75% and affective disorders in 4%-35% of prisoners. 

Mueser KT, Drake RE, Alterman AI Ackerson TH (1997). Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia. Journal of Abnormal Psychology, 106, 473-7... 

By far, the most important contributor to suicide is a serious psychiatric disorder, with MOD, bipolar disorder, schizophrenia, and substance abuse being most closely associated with suicide. The male-to-female ratio is less pronounced among psychiatric patients than in the general population, with a higher rate in unmarried psychiatric patients living alone. The lifetime probability of death by suicide in various psychiatric disorders is estimated to be between 10% and 15%, contrasting with less than a 1 % lifetime probability in those without a psychiatric disorder. 

Older persons account for one-third of all suicides in the United States even though this group represents only 12% of the population ( 36). Suicide is even more often related to major depression in the elderly than in younger individuals in whom other causes such as substance abuse, bipolar disorder, schizophrenia, and personality disorders often play a major role. In fact, suicide rates are highest in older white men relative to any other segment of the population. For example, white men older than 85 years age commit suicide 30 times as frequently as black women. 

FIGURE 10—6. Depressive and anxious symptoms are not only a hallmark of major depressive disorder but are frequently associated with other psychiatric disorders, including bipolar disorder, schizophrenia, and schizoaffective disorder with organic causes of depression, such as substance abuse with childhood mood disorders (child) with psychotic forms of depression and with mood and psychotic disorders resistant to treatment with drugs (treatment-resistant), among others. 

The dynamical diseases with altered dynamical complexity and rhythms in comparison with those during the normal states have been identified in many illnesses including depression, schizophrenia, epilepsy, substance abuse, Parkinson s disease, age-related diseases, osteoporosis, and hyperparathyroidism [41-48], For instance, affective problems such as depressive disorders have shown fluctuating state variables at both biological and psychological levels, and the complex phenomena in such diseases may be represented with the nonlinear interactions of these variables [49]. In another example, a nonlinear relationship has been established between obesity and diurnal cortisol secretion [50], In addition, chronic lymphocytic leukemia (CLL) has been found to be a dynamical disease as it is closely associated with B cell cycles [51]. Recent studies of microRNAs (miRNAs), their associations with cell cycle regulations and their roles in complex diseases such as... 

A thorough patient evaluation (e.g., history, mental status exam, physical exam, and laboratory analysis) should occur to establish a diagnosis of schizophrenia and to identify potential co-occurringdisorders, including substance abuse and general medical disorders. 

Psychosis—symptoms include irrational beliefs, paranoia, hallucinations (seeing things or hearing sounds that do not exist), social withdrawal, clinging, strange behavior, extreme stubbornness, persistent rituals, and deterioration of personal habits. May be seen in developmental disorders, severe depression, schizoaffective disorder, schizophrenia, and some forms of substance abuse. 

On the other hand, as discussed in later chapters, there s also considerable evidence that in industrialized countries an individual s season of birth may influence susceptibility to a wide range of psychological disorders, including schizophrenia, eating disorders, and substance abuse. 

DA is involved in movement disorders, as well as in schizophrenia and substance abuse. The neurotransmitter is synthesized from a precursor amino add tyrosine. L-tyrosine is hydroxylated to L-dopa by the action of the enzyme, tyrosine hydroxylase. L-dopa is then converted to DA by the L-aromatic amino acid enzyme decarboxylase. 

---